Arthneeti
Sale is live|00:00:00
Birlasoft LtdQ4 FY27

Birlasoft Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 308P/E: 16.1Market Cap: ₹8.8K CrSector: IT - Software

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 4
  • Q4 growth expected to be soft in Manufacturing and ERP segments due to one-off deal ramp-ups ending and lesser working days.
  • Management cautiously optimistic for Q4; confident about better deal wins and order bookings than Q3.
  • 10%-20% higher signings in Q4 over Q3 could ensure definite growth moving forward.
  • Healthcare segment faces pricing pressure but no volume degrowth expected in Q4 and partly in Q1 FY27.
  • Manufacturing headwinds may continue into Q4 but expected to stabilize and grow from Q1 or Q2 FY27.
  • Energy & Utilities (E&U) and Financial Services segments show steady growth momentum.
  • Shift towards fixed-price, outcome-based deals to reduce volume impact from fewer working days and improve margins.
  • Investments focused on sales, solutions, delivery capabilities to build pipeline and drive sustained revenue growth over coming quarters.

Margin guidance

Category 3
  • Management is focused on driving order book and revenue growth going forward, addressing past lack of strong growth.
  • Q4 growth is expected to be soft in Manufacturing and ERP segments due to one-off factors and lesser working days.
  • Confident that growth will return in future quarters with better deal signings; delivering 10-20% higher signings in Q4 compared to Q3 would signal growth.
  • EBITDA margin sustainable run rate expected around 15%, after accounting for one-offs and continuous investments in capabilities.
  • Investments focus on people, leadership, and capability building without relying on margin concessions.
  • Wage hikes planned for next financial year between Q1 and Q2.
  • Some pricing pressure anticipated in Healthcare due to client uncertainties but no volume decline expected.
  • Order booking for Q4 expected to be better than Q3; Q1 anticipated to be seasonally weaker for signings.

3 more insights locked — sign up free to unlock

Fundraise plans

  • There is no mention of any current or future plans for fundraising through debt or equity in the provided transcript.
  • The management focuses on capital allocation and enhancing operating efficiencies but has not indicated any intention to raise funds via debt or equity.
  • The Board of Directors is actively considering capital allocation strategies, including opportunistic investments and possible buybacks, but no specific fundraising plans are disclosed.
  • Emphasis is placed on using the existing cash pile (Rs. 2,491 crore at end of Q3) to invest in growth and capabilities.
  • The company is prioritizing sustaining margins and improving quality of revenue through internal investments rather than external fundraising.

Order book

Yes
  • The company maintains that H2 (second half) will be better than H1 regarding signings.
  • Q3 and Q4 order booking performance is expected to be an indication of improving order book.
  • Q4 is expected to deliver better order booking than Q3.
  • The focus is sharply on order book and revenue growth moving forward.
  • Pipeline creation and deal wins are being actively pursued to drive order book and revenue.
  • Deal wins in Q3 were strong, with $202 million TCV, up 89% quarter-on-quarter.
  • New engagements contribute nearly half of the deal wins.
  • The 4Q order intake is expected to be better, but revenue growth guidance is cautiously optimistic.

Capex plans

Yes
  • The company is focused on ongoing investments in capabilities necessary for future growth, particularly in people, leadership, and training resources aligned with business strategy. (Page 14)
  • Investments include growth-oriented areas such as the ROW region, which has recently delivered significant growth and margin improvement. (Page 16)
  • There is a strategic emphasis on moving away from staff augmentation towards more linear, outcome-based, and fixed-price deals, which supports offshore expansion and margin improvement. (Page 6)
  • The Board is actively engaged in capital allocation decisions, including opportunistic capabilities and investments that align with strategic objectives; no specific buyback plans are confirmed yet. (Page 16)
  • New leadership appointments (e.g., Komal for Americas) indicate increased investment in driving critical relationships and growing key markets. (Page 16)

How does Birlasoft Ltd rank vs peers in IT - Software?

Pro feature
1Birlasoft Ltd
Rev 4Mar 3

See full IT - Software sector rankings

Want more stocks like Birlasoft Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio